Contact   |   Login
Contact Us Banner Image

Contact Us

Pharmapex Group has a wide network of distributers and agents in North America and worldwide. To find out about the nearest distributor or sales office, please contact us using the questionnaire at the bottom of this page.

Pharmapex Group

U.S. Headquarters

402 West Broadway

San Diego, CA 92101, USA

Toll-Free (North America): 1-844-PHARMAPEX

Corporate Phone (International): +1-619-501-6158

Fax: +1-619-881-0035


Pharmapex Group

U.S. Mailing Address

402 West Broadway, fl 5

San Diego, CA 92101, USA

Pharmapex Group

East Coast Commercial Office

5 Penn Plaza, 19th-23rd Floors

New York, NY 10001, USA

Corporate Phone 1: +1-917-512-2387

Corporate Phone 2: +1-917-512-2386

Fax: +1-917-522-2122 Pharmapex Group

Colorado Distribution Center

1755 Telstar Drive

Colorado Springs, Colorado 80920, USA

Phone: +1-844-742-7627

Pharmapex Group

North America Field Office

4660 La Jolla Village Drive

San Diego, CA 92122, USA

Toll-Free (North America): 1-888-670-0590


Pharmapex Group

Wilmington Commercial Office

1521 Concord Pike

Wilmington, DE 19803, USA

Phone: +1-888-670-0590

To contact a specific department at Pharmapex, you can select from the addresses below:


Central and South America

Customer Support

Europe region

General Foods, North America


Middle East and Africa region

New Business Initiatives

North America region

Pacific Rim region


Request Information

Please tell us about your requirements by simply completing the confidential questionnaire below. We will reply back to you accordingly.

(Please tell us about your specific requirements)

Press Releases and Selected News:
Deferoxamine Mesylate Market to Witness Robust Expansion by 2029 with Teva api, Chengdu Easton Biopharmaceuticals, Pharmapex Group
The Deferoxamine Mesylate Report is a unique record that gives a total judgment of the market in terms of future patterns, development factors, creation volume, CAGR estimation, net revenue, cost, and industry-approved market data.

Pharmapex's novel mastitis treatment offers hope to world farmers
Efficient feed-based mastitis treatment boosts livestock health with a unique microencapsulated technology.

FDA approves Farxiga to treat type 2 diabetes
The U.S. FDA today approved Farxiga (dapaglifozin) tablets to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes.
© , Pharmapex USA, A member of Apex Group of Companies, All Rights Reserved.